Vaxcyte Inc’s filing revealed that its PRESIDENT AND CFO GUGGENHIME ANDREW unloaded Company’s shares for reported $0.69 million on Nov 18 ’24. In the deal valued at $85.81 per share,8,000 shares were sold. As a result of this transaction, GUGGENHIME ANDREW now holds 109,491 shares worth roughly $9.69 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, GUGGENHIME ANDREW bought 8,000 shares, generating $692,000 in total proceeds.
Before that, PICKERING GRANT sold 2,366 shares. Vaxcyte Inc shares valued at $245,796 were divested by the CHIEF EXECUTIVE OFFICER at a price of $103.89 per share. As a result of the transaction, PICKERING GRANT now holds 137,398 shares, worth roughly $12.17 million.
Mizuho initiated its Vaxcyte Inc [PCVX] rating to a Buy in a research note published on December 07, 2023; the price target was $69. A number of analysts have revised their coverage, including TD Cowen’s analysts, who began to cover the stock in mid April with a ‘”an Outperform”‘ rating. Needham also remained covering PCVX and reiterated its “Buy” recommendation on January 03, 2023. Guggenheim started covering the stock on December 15, 2022. It rated PCVX as “a Buy”.
Price Performance Review of PCVX
On Friday, Vaxcyte Inc [NASDAQ:PCVX] saw its stock jump 0.17% to $88.54. Over the last five days, the stock has gained 1.97%. Vaxcyte Inc shares have risen nearly 40.99% since the year began. Nevertheless, the stocks have risen 80.69% over the past one year. While a 52-week high of $121.06 was reached on 09/19/24, a 52-week low of $48.24 was recorded on 01/05/24. SMA at 50 days reached $107.89, while 200 days put it at $83.21.
Levels Of Support And Resistance For PCVX Stock
The 24-hour chart illustrates a support level at 87.21, which if violated will result in even more drops to 85.88. On the upside, there is a resistance level at 90.60. A further resistance level may holdings at 92.65. The Relative Strength Index (RSI) on the 14-day chart is 29.48, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -7.84, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 87.23%. Stochastics %K at 9.88% indicates the stock is a buying.
How much short interest is there in Vaxcyte Inc?
A steep rise in short interest was recorded in Vaxcyte Inc stocks on 2024-10-31, dropping by -0.73 million shares to a total of 8.93 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-30 was 9.65 million shares. There was a decline of -8.12%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on November 17, 2022 when BTIG Research began covering the stock and recommended ‘”a Buy”‘ rating along with a $69 price target.
